
|Videos|November 18, 2022
Dr. Myrga discusses techniques to leverage transperineal prostate biopsy benefits
Author(s)Urology Times staff
“When we think about all the other office-based procedures we do, such as transrectal biopsies and vasectomies that are done in-clinic, I think that technology can play a big role in these," says Dr. Myrga.
Advertisement
In an interview with Urology Times, John Myrga, MD, explains the significance of findings from his recent study, "Patient Reported Outcomes after Transperineal vs. Transrectal Biopsy with Local Anesthesia: Advances in Pain Control and Areas for Improvement." These findings were presented at the 74th Annual Meeting of the Northeastern Section of the American Urological Association. Myrga is a urology resident at University of Pittsburgh Medical Center’s urology department.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: AUA 2026 Update on Prostate Cancer Early Detection, With Badrinath R. Konety, MBBS
2
FDA approves enfortumab vedotin plus pembrolizumab for MIBC
3
Daniel George, MD, on the significance of the capivasertib approval for PTEN-deficient prostate cancer
4
EV plus pembro approval reframes first conversation in MIBC diagnosis
5













